These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22335894)
1. New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series. Stauffer F; Furet P; Floersheimer A; Lang M Bioorg Med Chem Lett; 2012 Mar; 22(5):1860-3. PubMed ID: 22335894 [TBL] [Abstract][Full Text] [Related]
2. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors. Neves MA; Dinis TC; Colombo G; Sá e Melo ML Eur J Med Chem; 2009 Oct; 44(10):4121-7. PubMed ID: 19500885 [TBL] [Abstract][Full Text] [Related]
3. Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19). Muftuoglu Y; Mustata G Bioorg Med Chem Lett; 2010 May; 20(10):3050-64. PubMed ID: 20413308 [TBL] [Abstract][Full Text] [Related]
4. Investigation of aryl halides as ketone bioisosteres: refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase). McNulty J; Nielsen AJ; Brown CE; DiFrancesco BR; Vurgun N; Nair JJ; Crankshaw DJ; Holloway AC Bioorg Med Chem Lett; 2013 Nov; 23(22):6060-3. PubMed ID: 24113062 [TBL] [Abstract][Full Text] [Related]
5. The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents. Lu WJ; Xu C; Pei Z; Mayhoub AS; Cushman M; Flockhart DA Breast Cancer Res Treat; 2012 May; 133(1):99-109. PubMed ID: 21814747 [TBL] [Abstract][Full Text] [Related]
6. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer. Ahmad I; Shagufta Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones. Kim YW; Hackett JC; Brueggemeier RW J Med Chem; 2004 Jul; 47(16):4032-40. PubMed ID: 15267241 [TBL] [Abstract][Full Text] [Related]
8. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation. Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors. Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer. Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269 [TBL] [Abstract][Full Text] [Related]
11. Aromatase: the enzyme and its inhibition. Banting L; Ahmed S Anticancer Agents Med Chem; 2009 Jul; 9(6):627-41. PubMed ID: 19601746 [TBL] [Abstract][Full Text] [Related]
12. Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer. Abdalla MM; Al-Omar MA; Bhat MA; Amr AG; Al-Mohizea AM Int J Biol Macromol; 2012 May; 50(4):1127-32. PubMed ID: 22361454 [TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibitors: structural features and biochemical characterization. Hong Y; Chen S Ann N Y Acad Sci; 2006 Nov; 1089():237-51. PubMed ID: 17261771 [TBL] [Abstract][Full Text] [Related]
14. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities. Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362 [TBL] [Abstract][Full Text] [Related]
15. Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity. Wood PM; Woo LW; Labrosse JR; Trusselle MN; Abbate S; Longhi G; Castiglioni E; Lebon F; Purohit A; Reed MJ; Potter BV J Med Chem; 2008 Jul; 51(14):4226-38. PubMed ID: 18590272 [TBL] [Abstract][Full Text] [Related]
16. Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors. Neves MA; Dinis TC; Colombo G; Sá e Melo ML J Med Chem; 2009 Jan; 52(1):143-50. PubMed ID: 19072235 [TBL] [Abstract][Full Text] [Related]
17. Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies. Nagar S; Saha A Eur J Med Chem; 2010 Sep; 45(9):4307-15. PubMed ID: 20638757 [TBL] [Abstract][Full Text] [Related]
18. Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors. Su B; Hackett JC; Díaz-Cruz ES; Kim YW; Brueggemeier RW Bioorg Med Chem; 2005 Dec; 13(23):6571-7. PubMed ID: 16125392 [TBL] [Abstract][Full Text] [Related]
19. Potent aromatase inhibitors and molecular mechanism of inhibitory action. Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405 [TBL] [Abstract][Full Text] [Related]
20. Aromatase inhibitors: Role in postmenopausal breast cancer. Kharb R; Haider K; Neha K; Yar MS Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000081. PubMed ID: 32449548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]